The American Recovery and Reinvestment Act of 2009 invested $1.1 billion in federal initiatives to begin the important and necessary work of comparative effectiveness research (CER), a key building block in health care reform. However, whether CER can fulfill expectations of better quality, outcomes and value in health care will depend on how it is implemented.
A forum hosted by the Engelberg Center for Health Care Reform and The Hamilton Project addressed many of the key questions surrounding CER and featured remarks from Sen. Max Baucus (D-Mont.) and Office of Management and Budget Director Peter Orszag. Three discussion papers released at the event focus on how research questions should be prioritized, what methods and data infrastructure are needed for CER, and how CER findings can be used to improve clinical and health policy decisions. A series of distinguished panels discussed the papers’ findings.
Participants took questions after each panel.
Director, Center for Primary Care and Outcomes Research, Stanford School of Medicine
Associate Professor, University of Chicago School of Medicine
Executive Director - Medicare Payment Advisory Committee
Director, National Heart, Lung, and Blood Institute
Past President, American College of Physicians
Director, Institute for Clinical and Economic Review
Senior Health Policy Analyst, Consumers Union
Vice President, Global Health Outcomes, Eli Lilly & Co.
Executive Vice President, Clinical Health Policy and Chief Medical Officer - WellPoint, Inc.
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.